Prolight Diagnostics Selects G&H | ITL To Develop Commercial Instrument

Prolight Diagnostics today announces that it has selected G&H | ITL to develop the commercial instrument for its point-of-care digital immunoassay system.

This next stage of product development builds on the prototypes developed in-house at Prolight’s subsidiary Psyros Diagnostics (“Psyros”) and will ensure that the commercial instrument is state of the art and in compliance with all regulatory standards required for an IVD.

“We believe the best approach is to partner with experts in their field who can help us deliver on our vision to develop ground-breaking products for our customers. Partnering with G&H | ITL gives us an outstanding combination of technical expertise, track-record, flexibility, longer-term manufacturing capability and regulatory compliance,” said Paul Monaghan, head of engineering at Psyros.

“We are excited to join the Psyros adventure as an external partner. The team is highly capable, and it has come up with a most innovative, yet simple and elegant new IVD technology which promises to improve point of care testing worldwide. We will bring our strong capabilities and skills in the field of optics, mechanical engineering, and intimate knowledge of the manufacturing process to the table,” said Tom Ackrill, Business Development Manager at G&H | ITL.